Analyst Reco. Novo Nordisk A/S

Equities

Real-time Estimate Cboe Europe Other stock markets 07:24:05 2024-05-16 am EDT			5-day change	1st Jan Change
915.9 ^DKK	-0.13%		+0.47%	+30.96%

09:25am	Roche shares gain on obesity drug results from early-stage trial	RE
06:41am	US Senate Committee Warns of Potential Healthcare Bankruptcy Due to Novo Nordisk's Wegovy	MT

NOVO NORDISK : UBS sticks Neutral	May. 15	ZD
NOVO NORDISK : JP Morgan reaffirms its Buy rating	May. 14	ZD
NOVO NORDISK : UBS reaffirms its Neutral rating	May. 14	ZD
Stifel Lifts Novo Nordisk PT, Keeps Buy Recommendation	May. 14	MT
NOVO NORDISK : Stifel raises its target price	May. 14	CF
Novo Nordisk Reportedly Asked by US Senator to Reduce Prices of Ozempic, Wegovy Drugs in US	May. 13	MT
Novo Nordisk Plans First Bond Sale in 2 Years	May. 13	MT
NOVO NORDISK : Berenberg reiterates its Neutral rating	May. 08	ZD
Novo Nordisk Seeks More Time to Address US Sen. Bernie Sanders' Questions on Drug Pricing	May. 07	MT
NOVO NORDISK : Barclays remains its Buy rating	May. 07	ZD
NOVO NORDISK : UBS sticks Neutral	May. 06	ZD
Novo Nordisk: share price falls, analyst adjusts target	May. 03	CF
NOVO NORDISK : DZ Bank sticks Neutral	May. 03	ZD
NOVO NORDISK : Stifel lowers target slightly	May. 03	CF
NOVO NORDISK : Buy rating from Deutsche Bank	May. 03	ZD
Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data	May. 03	RE
NOVO NORDISK : JP Morgan gives a Buy rating	May. 03	ZD
NOVO NORDISK : Q1 beat; guidance upgrade but sentiment nonetheless dampened by price reductions	May. 02
NOVO NORDISK : Gets a Buy rating from Barclays	May. 02	ZD
NOVO NORDISK : UBS gives a Neutral rating	May. 02	ZD